|
|
EGFR Signaling and Drug Discovery
|
Breast Cancer: Investigators at Harvard University, Dana-Farber Cancer Institute have published new data on breast cancer
|
Bladder cancer treatment with gene therapy shows promise
|
Angiogenesis: Scientists at RIKEN detail research in angiogenesis
|
The Ludwig Institute and Pro-Pharmaceuticals Collaborate to Test Davanat's Ability to Enhance the Function of
|
The Ludwig Institute and Pro-Pharmaceuticals Collaborate to Test DAVANATEURs Ability to Enhance the Functi
|
Study findings from Kitasato University, Japan, update colon cancer knowledge
|
Researchers' work from University of Heidelberg, Germany, adds to body of knowledge
|
VIVALIS EBx Proof of Concept for Production of Antibodies
|
New studies from St. Jude Children's Research Hospital, Memphis, U.S., outlined
|
Reports from the United States, the United Kingdom and Italy highlight recent research in ovarian cancer
|
Data Available From ERBITUX(R) Phase III Study in First-Line Treatment of Advanced Lung Cancer
|
Studies from University of Texas, M. D. Anderson Cancer Center describe new findings in cancer gene therapy
|
Abbott and Genentech Announce Global, Integrated Research, Development and Commercialization Collaboration in Oncology
|
Abbott and Genentech Announce Global, Integrated Research, Development and Commercialization Collaboration in Oncology
|
Researchers from the United States provide details of new studies and findings in the area of breast cancer
|
Researchers' work from University of Munich, Germany, adds to body of knowledge
|
Studies from the United States and Australia yield new prostate cancer data
|
Phase 2 Results for EntreMed's Panzem NCD Brain Cancer Study Presented at ASCO
|
Pain & Central Nervous System Week via NewsRx.com:
|
similar ...
| |
|
New activities and developments reported by Eli Lilly and Company
|
